10.18.2023

SonoMotion initiates Break Wave pivotal trial (SOUND) at ten sites in the United States and Canada.

09.22.2022

SonoMotion receives FDA Breakthrough Device Designation for Break Wave™ procedure.

08.15.2022

Sonomotion raises USD$12.4 Million in Series C funding to advance development of Break Wave™. Round co-led by UWH LLC and Advance MedTech Holdings Pte. Ltd.

05.13.2022

Come visit SonoMotion at the American Urological Association conference in New Orleans on May 13-15 (Booth #1909).

05.05.2022

First of its kind procedure successfully conducted by SonoMotion and Vancouver Aquarium on Hermes, a harbor seal suffering from kidney stones (press release and video).